Analyst Expect Big Moves From Biocryst Pharmaceuticals Inc (NASDAQ: BCRX)
Currently, there are 205.77M common shares owned by the public and among those 195.87M shares have been available to trade. The company’s stock has a 5-day price change of -9.82% and -6.61% over the past three months. BCRX shares are trading 22.70% year to date (YTD), with the 12-month market performance up to 30.32% higher. […]
Better Times Ahead For Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX)?
Biocryst Pharmaceuticals Inc. (BCRX) concluded trading on Thursday at a closing price of $7.12, with 2.42 million shares of worth about $17.25 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 39.61% during that period and on October 10, 2024 the price saw a […]
Investors Should Take Note Of Biocryst Pharmaceuticals Inc. (BCRX)
Biocryst Pharmaceuticals Inc. (BCRX) concluded trading on Wednesday at a closing price of $5.57, with 4.17 million shares of worth about $23.21 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -19.74% during that period and on Wednesday the price saw a gain of […]
Stick With Biocryst Pharmaceuticals Inc. (BCRX). The Bull Are Alive And Well
The Vanguard Group, Inc. recently announced the acquisition of new stake in Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX). The institutional investor has increased its shareholding in the Healthcare company by 2.08% to 14.9 million shares with purchase of 0.3 million shares. This fresh investment now brings its stake to 7.28% valued currently at $87.61 million. In addition, […]
Is Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) Proving The Doubters Wrong?
Biocryst Pharmaceuticals Inc. (BCRX) concluded trading on 01/04/24 at a closing price of $6.46, with 3.96 million shares of worth about $25.57 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -7.18% during that period and on Thursday the price saw a gain of […]
Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) Stock In Prove Me State
The Vanguard Group, Inc. has recently announced that it has increased stake in Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) by 2.08%. After grabbing 14.9 million shares, the institutional investor is now in possession of 0.3 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.28% having worth around $87.61 million. […]
These Numbers Could Change Investor Views For Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX). The institutional investor has increased its shareholding in the Healthcare company by 2.08% to 14.9 million shares with purchase of 0.3 million shares. This fresh investment now brings its stake to 7.28% valued currently at $87.61 million. In addition, […]
